SCHEMBL29128697

SCHEMBL29128697

[CH2]C(=O)NC(=O)Nc1cccnc1OC

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.45
P2RY1 P47900 6/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 3/20 0.43
MAPK1 P28482 2/20 0.43
TP53 P04637 1/20 0.43
MECP2 P51608 1/20 0.43
NAMPT P43490 1/20 0.43
ALDH1A1 P00352 3/20 0.42
ATR Q13535 1/20 0.42
POLB P06746 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.41
P2RY14 Q15391 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30725362 0.82 SMN1; SMN2 (0.46) GFERP2RY1SMN1; SMN2MAPTMAPK1
SCHEMBL29128651 0.82 SMN1; SMN2 (0.46) GFERP2RY1SMN1; SMN2MAPTMAPK1
SCHEMBL50243 0.80 MEN1 (0.55) GFERSMN1; SMN2MAPTNAMPTALDH1A1
SCHEMBL1725253 0.80 ALDH1A1 (0.49) GFERP2RY1SMN1; SMN2MAPTNAMPT
SCHEMBL29128670 0.76 MAPK1 (0.47) MAPK1NAMPT
SCHEMBL8495853 0.76 CETP (0.47) GFERP2RY1SMN1; SMN2ALDH1A1ATR
SCHEMBL12182365 0.76 BRD4 (0.50) SMN1; SMN2MAPTMAPK1NAMPTALDH1A1
SCHEMBL27483343 0.74 FNTA (0.49) SMN1; SMN2MAPTALDH1A1POLBMEN1
SCHEMBL1723318 0.73 METAP1 (0.54) P2RY1NAMPTALDH1A1ATRP2RY14
SCHEMBL30283184 0.73 METAP1 (0.54) P2RY1NAMPTALDH1A1ATRP2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117263873-A 1, 4-benzodiazepine compounds and application thereof in preparation of antitumor drugs 复旦大学 2023-12-22 CN disclosed